Jim Cramer Says Government Probe Not a Reason to Sell Valeant, But There are Other Reasons

The government's investigation into Valeant (VRX) isn't a reason to sell the stock, but there are plenty of other reasons not to own it, according to TheStreet's Jim Cramer. He says you shouldn't like Valeant for the balance sheet and for the fact that they company has overpromised and may see drug prices roll back. As far as the investigation goes, Cramer says the government is simply playing catch-up. He points out that an investigation into Bristol-Myers  (BMY) - Get Report  by the government years ago resulted in Bristol's stock rising.